Chipman Inc. – Trademark Portfolio

Entity Type: 03

Chipman Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. The owner is based in Stoney Creek, Ontario.

400 Jones Rd.

Stoney Creek, Ontario L8G 3Z1 , CA

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KERILUX
KERILUX
Cancelled 1982
KERIGARD
KERIGARD
Cancelled 1982
ATRA-MIX
ATRA-MIX
Cancelled 1981
SWEEP
SWEEP
Cancelled 1980
CHIPMAN
CHIPMAN
Cancelled 1980

Trademark Classifications

Chipman Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does Chipman Inc. have?

Chipman Inc. has 7 U.S. trademarks filed with the USPTO.

What trademark classes does Chipman Inc. file in?

Chipman Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Chipman Inc.'s trademark registration success rate?

Chipman Inc. has a 0% trademark registration rate, with 0 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.